Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00601354 · ClinicalTrials.gov registry record · NA
Adding Guided Self-Help Group Therapy to the Alli Weight Loss Program in Treating Binge Eating Disorder
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT00601354: Completed NA study, sponsored by Stanford University.
NCT00601354 is a NA study that has completed, run by Stanford University. The registered enrollment target is 17 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00601354, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
This study will evaluate the effectiveness of adding guided self-help group therapy to a weight loss program in achieving weight loss and reducing binge eating in overweight binge eaters.
Interventions
- BEHAVIORAL Emotion regulation group therapy
- DRUG Orlistat/alli program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2007-09 |
| Est. Completion | 2008-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00601354
The ClinicalTrials.gov registry entry for NCT00601354 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Emotion regulation group therapy is the first listed.
NCT00601354 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00601354 about?
NCT00601354 is a clinical study titled "Adding Guided Self-Help Group Therapy to the Alli Weight Loss Program in Treating Binge Eating Disorder". This study will evaluate the effectiveness of adding guided self-help group therapy to a weight loss program in achieving weight loss and reducing binge eating in overweight binge eaters.
What is the current status of trial NCT00601354?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2007-09. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00601354?
The interventions under investigation include: Emotion regulation group therapy (BEHAVIORAL), Orlistat/alli program (DRUG).
Who is sponsoring clinical trial NCT00601354?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.